Markets:

Overview

News

Currencies

International

Treasuries

Thermo Fisher Scientific (NY:TMO)

578.71 -1.42 (-0.24%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

30 31 Next >

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

3 Dividend Stocks Raising Their Payouts by 10% or More This Year ↗

March 07, 2023

Can you count on these distributions to continue rising?

Via The Motley Fool

$1000 Invested In Thermo Fisher Scientific 5 Years Ago Would Be Worth This Much Today ↗

March 07, 2023

Via Benzinga

Thermo Fisher Scientific to Present at Cowen 43rd Annual Healthcare Conference on March 6, 2023

February 28, 2023

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific Increases Quarterly Dividend

February 22, 2023

From Thermo Fisher Scientific Inc.

Via Business Wire

Preview: Thermo Fisher Scientific's Earnings ↗

January 31, 2023

Via Benzinga

Here's How Much $1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today ↗

January 30, 2023

Via Benzinga

Expert Ratings for Thermo Fisher Scientific ↗

January 24, 2023

Via Benzinga

Got $5,000? These 2 Low-Risk Growth Stocks Also Pay Dividends ↗

February 22, 2023

These stocks would have more than doubled your money in the past five years.

Via The Motley Fool

3 Large-Cap Biotech Stocks to Hold for the Long Haul ↗

February 19, 2023

These three large-cap biotech stocks survived or went up in 2022 when most of the market went down by double digits.

Via InvestorPlace

Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here' ↗

February 08, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending."

Via Benzinga

Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗

February 06, 2023

Danaher is reportedly looking to add to its wheelhouse to compete with Thermo.

Via Investor's Business Daily

Is Thermo Fisher Scientific Stock a Buy Now? ↗

February 04, 2023

Now that China's concluded its zero-COVID policy, Thermo Fisher Scientific expects rapid growth in its second-largest end market.

Via The Motley Fool

Will Investors Notice Exciting Sign On Thermo Fisher Scientific's Chart? ↗

January 19, 2023

Via Benzinga

$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today ↗

January 11, 2023

Via Benzinga

Thermo Fisher Scientific To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday ↗

February 02, 2023

Keefe, Bruyette & Woods boosted the price target for Evercore Inc. (NYSE: EVR) from $132.5 to $137. Keefe, Bruyette & Woods analyst Matthew Moon maintained an Outperform rating. Evercore shares rose 1%...

Via Benzinga

Darden Restaurants, Copart And This Diagnostics Company Feature On CNBC's 'Final Trades' ↗

February 02, 2023

On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management chose Thermo Fisher Scientific Inc. (NYSE: TMO), which

Via Benzinga

Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity

February 02, 2023

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific (TMO) Q4 2022 Earnings Call Transcript ↗

February 01, 2023

TMO earnings call for the period ending December 31, 2022.

Via The Motley Fool

Dow Dips 300 Points; Snap Shares Plunge ↗

February 01, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500...

Via Benzinga

Thermo Fisher Says 2022 Another Exceptional Year, Well Positioned While Entering 2023 ↗

February 01, 2023

Via Benzinga

US Stocks Open Lower; Dow Drops 125 Points ↗

February 01, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 125 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.37% to 33,960.34 while the NASDAQ fell...

Via Benzinga

Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report ↗

February 01, 2023

Thermo Fisher provided a bullish outlook, while Boston Scientific's profit view was short.

Via Investor's Business Daily

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results

February 01, 2023

From Thermo Fisher Scientific Inc.

Via Business Wire

Earnings Scheduled For February 1, 2023 ↗

February 01, 2023

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.

Via Benzinga

Meta Platforms, Snap And 3 Stocks To Watch Heading Into Wednesday ↗

February 01, 2023

With US stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Optimism Improves Ahead Of Fed's Decision ↗

February 01, 2023

The CNN Money Fear and Greed index showed some improvement in overall sentiment among US investors. US stocks closed higher on Tuesday ahead of the much-awaited policy decision from the Federal...

Via Benzinga

Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

January 24, 2023

Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading.

Via Benzinga

Healthcare Sector Is Lagging As We Enter 2022 Earnings Season ↗

January 23, 2023

The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength.

Via Talk Markets

J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗

January 17, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.

Via Talk Markets

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

30 31 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Thermo Fisher Scientific (NY:TMO)

All News about Thermo Fisher Scientific

Starting at $3.75/week.

Subscribe Today